Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 6

1.

Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles.

Stephan MT, Stephan SB, Bak P, Chen J, Irvine DJ.

Biomaterials. 2012 Aug;33(23):5776-87. doi: 10.1016/j.biomaterials.2012.04.029. Epub 2012 May 15.

2.

Modulation of tumor immunity by soluble and membrane-bound molecules at the immunological synapse.

González PA, Carreño LJ, Céspedes PF, Bueno SM, Riedel CA, Kalergis AM.

Clin Dev Immunol. 2013;2013:450291. doi: 10.1155/2013/450291. Epub 2013 Mar 7. Review.

3.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
4.

Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancer.

Gardner TA, Elzey BD, Hahn NM.

Hum Vaccin Immunother. 2012 Apr;8(4):534-9. doi: 10.4161/hv.19795. Review.

PMID:
22832254
5.

Advances in specific immunotherapy for prostate cancer.

Kiessling A, Füssel S, Wehner R, Bachmann M, Wirth MP, Rieber EP, Schmitz M.

Eur Urol. 2008 Apr;53(4):694-708. Epub 2007 Nov 26. Review.

PMID:
18061335
6.

The immunological synapse.

Dustin ML.

Cancer Immunol Res. 2014 Nov;2(11):1023-33. doi: 10.1158/2326-6066.CIR-14-0161. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk